(Q42861088)

English

Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer

scientific article published on October 12, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer (English)

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

single-nucleotide polymorphism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20940192

1 August 2024

2

object named as

Takashi Kohno

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

Kouya Shiraishi

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Chiharu Tanai

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Yasushi Goto

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Aya Kuchiba

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Seiichiro Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Koji Tsuta

7

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Hiroshi Nokihara

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Noboru Yamamoto

9

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Ikuo Sekine

10

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Yuichiro Ohe

11

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Tomohide Tamura

12

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Jun Yokota

13

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Hideo Kunitoh

14

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

language of work or name

0 references

publication date

12 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

full work available at URL

http://intl.jco.org/cgi/content/abstract/28/33/4945

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20940192

1 August 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.5334

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

4945-4952

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Global cancer statistics, 2002

1

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review

2

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

3

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

4

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

5

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

6

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.

7

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

9

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

10

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

11

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.

12

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

13

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy

14

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.

15

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

16

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

The new World Health Organization classification of lung tumours

18

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel

19

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma

20

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese

21

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

24

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

25

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs

26

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

The PARP superfamily

27

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Synthetic lethality--a new direction in cancer-drug development

28

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells

29

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients

30

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

31

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy

32

1 reference

10.1200/JCO.2010.30.5334

https://api.crossref.org/works/10.1200/JCO.2010.30.5334

1 August 2024

Identifiers

10.1200/JCO.2010.30.5334

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

release_y6q7md2gfbeihhbzrztbojinra

1 reference

https://api.fatcat.wiki/v0/release/y6q7md2gfbeihhbzrztbojinra

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42861088&oldid=2217696659"